Clinical trial
Clinical Efficacy Analysis of Resveratrol in the Treatment of Primary Ovarian Insufficiency
NCT05410093 is registered in ClinicalTrials.gov with Affiliated Hospital of Nantong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Efficacy Analysis of Resveratrol in the Treatment of Primary Ovarian Insufficiency
- Lead sponsor
- Affiliated Hospital of Nantong University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 1, 2022
- Completion date
- July 31, 2024
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.